Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07221552 · ClinicalTrials.gov registry record · NA

Evaluation of the PPAL

A NA study of Age Problems, sponsored by Alicia Koontz.

Recruiting
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT07221552: Recruiting NA study of Age Problems, sponsored by Alicia Koontz.

NCT07221552 is a NA study of Age Problems that is actively recruiting participants, run by Alicia Koontz. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07221552, a NA study of Age Problems, is actively recruiting participants, sponsored by Alicia Koontz.

RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This research study is being conducted to better understand the impact of the PPAL assisted toileting device. The PPAL consists of a powered, height-adjustable commode chair with integrated transfer boards. The system is designed to allow users to assist with their own transfers to and from the bed or chair to the PPAL for toileting, with minimal manual assistance from caregivers. Users who require assistance with transfers, and their caregivers, have a high likelihood of experiencing injury during transfers. The purpose of this study is to evaluate the PPAL bedside commode in a home setting to better understand the impact of the device during a six-week at-home trial. Participants will be asked to schedule a home visit with the research team to screen their home, answer questions, and observe the participant's current transfer methods to their toilet or commode to ensure that both the participant and caregiver are appropriate candidates for the device. Once approved, a delivery date will be arranged to deliver the PPAL to the participant's home. At the end of the six-week trial, the study team will arrange a final visit to retrieve the PPAL and again ask questions and observe a toilet transfer using both the PPAL and the customary commode. Finally, the investigators will interview the participant and caregiver to assess their satisfaction with the device. This interview will be audio recorded. This study involves minimal risks, which are expected to occur infrequently. There is a possibility that the participant could experience a scrape, bruise, cut, or pinch injury while using a device with which they are not familiar. There is also the possibility that the participant could fall when attempting to transfer to or from the device; however, the investigators will thoroughly demonstrate the device and monitor its use to minimize this risk. There is also a risk of breach of confidentiality, as text messages and emails may not be encrypted or secure during transmiss

Primary Outcome

We aim to determine whether the use of PPAL reduces fear of falling during toileting activities. To assess this, we will utilize the Fall Concerns Scale for individuals who use Wheelchairs and Scooters (FCS-WC/S). Items are scored on a scale of concern, with 1 being "Not at all concerned" and 4 being "Very Concerned". Scores can be analyzed from specific questions, or the questionnaire as a whole. For this result we will focus on the item specifically associated with getting on/off of a toilet o

Conditions Studied

Interventions

  • DEVICE PPAL

Study Locations (1)

Pennsylvania

  • University of Pittsburgh: Human Engineering Research Laboratories - Pittsburgh

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2026-01-20
Est. Completion 2026-08-31
Phase NA
Alicia Koontz

3 total trials

What NCT07221552 shows while recruiting

NCT07221552 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Age Problems appearing as the primary indexed condition, and to 1 intervention - of which PPAL is the first listed.

NCT07221552 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07221552 about?

NCT07221552 is a clinical study titled "Evaluation of the PPAL". This research study is being conducted to better understand the impact of the PPAL assisted toileting device. The PPAL consists of a powered, height-adjustable commode chair with integrated transfer boards. The system is designed to allow users to assist with their own transfers to and from the bed ...

What is the current status of trial NCT07221552?

This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2026-01-20. Estimated completion is 2026-08-31.

What conditions does trial NCT07221552 study?

This clinical trial studies the following conditions: Age Problems.

What interventions are being tested in trial NCT07221552?

The interventions under investigation include: PPAL (DEVICE).

Who is sponsoring clinical trial NCT07221552?

This trial is sponsored by Alicia Koontz, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07221552 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT07221552's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07221552, the US trial registry maintained by the National Library of Medicine. NCT07221552 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.